Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
about
Clinical Development of the E75 Vaccine in Breast CancerImmunogenomics: using genomics to personalize cancer immunotherapy.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Breast Cancer Vaccines: New Insights.Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.In silico prediction of cancer immunogens: current state of the art.Membrane Active Peptides and Their Biophysical Characterization
P2860
Q26745440-B3515EEA-CB63-435F-8389-CA81CD39C549Q38772744-85AAC1E9-2D7A-44AE-9509-F1EF1491D5E5Q39450802-1BF0CB2C-A28D-417B-B0A6-A6FCFDE38C62Q42683276-00BC0163-B9B9-4C25-9FF2-DCE0D35C6359Q47143266-ECF3BB56-41F0-456F-8B65-57A6B12F9287Q47565901-F3166561-7DD6-42F1-BCB9-93FB94802AE1Q55385621-D266137D-2C1E-4EB6-B99E-78A7754DF38DQ58717273-3BEFBAFA-D943-4490-AD3A-A276F01C6E23
P2860
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
@en
type
label
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
@en
prefLabel
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
@en
P2093
Elizabeth A Mittendorf
George E Peoples
Guy T Clifton
P2860
P304
P356
10.2217/IMT.15.81
P577
2015-11-16T00:00:00Z